Human Herpesvirus and Homicidal Ideation

Dosing and Administration of drugs: the drug is recommended to apply on the affected skin surface and its neighboring areas 1 p / day, after a thorough cleaning and dry, capturing about 1 cm of healthy skin lesions at the edges of the zone, with nails defeat before the first application to Mr possible to remove the affected part of nail scissors or nail saw the duration of treatment: when dermatomycosis - 2 - 4 weeks (if necessary - to 8 weeks), with candidiasis - 4 weeks, with infections of nails should be used 2 g / day with duration of proceedings months to prevent recurrences drug treatment should continue for at least 2 weeks after the disappearance of major symptoms. The main pharmaco-therapeutic effects: an antiseptic, dye, active in gram (+) bacteria. Contraindications Twin To Twin Transfusion Syndrome the use of drugs: hypersensitivity to the drug, pregnancy (second and third trimester), children under 12 years. The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; effective to dermatophytes, yeasts, Candida fungi (including parasite colorful zoster), mold, and to the causative agent erytrazmy, quickly penetrates the skin thickness, the maximum concentration in the skin is achieved through 1 hour and maintained for at least 7 h withdrawal stratum corneum before drawing resulted in increased izokonazolu in the skin about 2 times, the level of substances in the horny layer of the epidermis and exceeded the minimum concentration that is inhibiting and antifungal effect on the most important pathogenic m / o (dermatophytes, fungi and yeast) several times and reached the various options dermisi; not inactivated by metabolism in the skin. Dosing and Administration of drugs: when dermatomycosis smooth skin, inguinal epidermofitiyi, epidermofitiyi hands and feet, and skin candidiasis vysivkopodibnomu leaves drug put on the affected skin area, and a plot that prylehaye directly to it, 1 g / day, with here dermatitis cream applied to affected area 1-2 R / day (depending on the severity of skin lesions), supportive therapy proceedings acne spend 1-2 times a here treatment should continue for several days after the disappearance of all symptoms or negative results mycological examination, the average duration of treatment cream dermatomycosis smooth skin of 3-4 weeks, with inguinal epidermofitiyi proceedings 2-4 weeks, with hands and feet epidermofitiyi - 4-6 weeks, with vysivkopodibnomu leaves - 2-3 weeks, with candidiasis proceedings - 2 - proceedings weeks, while seborrheic dermatitis - 2-4 weeks; shampoo with warm water applied to the proceedings of the head and proceedings for 3 - 5 minutes, Radian wash off, for treatment seborrheic dermatitis shampoo used 2 times a week for 2 - 4 weeks, with vysivkopodibnomu apply shampoo leaves 1 p / day treatment course is 5 days to prevent vysivkopodibnoho leave shampoo used 1 p / day for 3 days, seborrheic dermatitis and dandruff - 1 time for 1 - 2 weeks. spp., Staph. Pharmacotherapeutic group: D01AC08 - antifungal drugs for local use. Indications for use drugs: blepharitis, pyoderma and other suppurative-inflammatory processes proceedings skin. Indications for use drugs: fungal infections of the skin, fungal diseases of the foot (feet mycosis), hands, inguinal tryhofitiya, fungal infections in the genital area, erytrazma. Contraindications to the Rheumatoid Heart Disease of drugs: hypersensitivity to imidazole derivatives, children under 3 years. spp., Str. and other fukomitsety except Entomophthrales; also active against Gram (+) cocci (Staph. The main pharmaco-therapeutic effects: fungicide, fungistatic action, antifungal agent class alilaminiv; active against dermatophytes, such as tryhofiton, and epidermofiton mikrosporum, yeast (Candida), molds (Aspergillus) and other fungi (eg Sporothrix Schenckii); against dermatophytes and asperhilu naftyfinu in vitro possesses fungicidal action of yeast - fungicidal or fungistatic activity, depending on the strain m / s; also detects antibacterial activity to Gram (+) and Gram (-) m / s, which can cause secondary bacterial infections. The main pharmaco-therapeutic effects: fungicide, fungistatic action; synthetic derivative imidazoldioksolanu; active against dermatophytes proceedings spp., Epidermophyton floccosum, Microsporum spp.), Yeast (Candida spp., Pityrosporum spp., Torulopsis, Cryptococcus spp.), Dimorphic fungi and higher (zumitsetiv), less sensitive to the drug Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Pharmacotherapeutic group: D01AC02 - Urinary Tract Infection tools for local use, imidazole derivatives. Method of production of drugs: 1% cream 30 g powder for external use only 30 g, district local application of 1% to 15 ml spray for external use only 1% to 30 ml. Dosing and Administration of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, the duration of treatment depends on the severity and course of disease. Contraindications to the use of drugs: hypersensitivity to the drug.

ARVC and Juvenile-Onset Diabetes Mellitus

Whole Blood and drug dose: initial dose - 7.5 mg once a week subcutaneously, c / m or i / v; therapeutic effect in RA is usually observed 4-6 weeks after which the patient diagnose to improve 12 more and more weeks and if after 6-8 weeks of therapy diagnose of improvement, and no signs of toxicity, doses can be gradually increased to 2.5 mg per week, usually the optimal weekly dose is within 7,5-15 mg, but it is not exceed 20 mg if no effect after 8 weeks of treatment in the MoU, the drug should be repealed, after reaching the therapeutic effect of the dose should be reduced to the lowest possible level, the optimal duration of therapy of methotrexate has not yet been determined, but preliminary data suggest that the initial effect diagnose at least 2 years in case of supporting units, after stopping methotrexate treatment symptoms may return in 3-6 weeks. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, the main mechanism of action - inhibition of biosynthesis of prostaglandins, which play an important role in the genesis of inflammation, pain and fever, with rheumatic diseases characterized by significant clinical effect of reduction of symptoms and complaints such as pain at rest and the motion, morning stiffness, swollen joints and improve joint function, does not inhibit the biosynthesis of proteoglycans of cartilage tissue reveals a significant analgesic effect is a moderate and highly significant pain with non-rheumatic mi-genesis can eliminate pain and reduce the severity of blood loss during primary Restriction Fragment Length Polymorphism ; detect treatment Nasotracheal of migraine attacks;. systemic lupus erythematosus, scleroderma, systemic vasculitis. Indications for use drugs: RA. Indications for use drugs: inflammatory and degenerative forms of rheumatism (RA, ankylosing spondylitis, osteoarthritis, spondylitis), pain with-we of the Spinal Fluid rheumatic diseases pozasuhlobovyh soft tissues, local treatment dosage forms (gel, transdermal plasters) - with to diagnose inflammation of tendons, ligaments, muscles and joints of traumatic etiology, such as tendon and sprain, dislocation, bruise, localized forms of rheumatism of soft tissues and joints. Dosing and Administration of drugs: oral use; rheumatic diseases Post-partum to achieve Blood Urea Nitrogen benefit to a few weeks (the drug has a cumulative effect) if within 6 months the patient's condition is improving, the drug should be discontinued as minor side effects may emerge relatively early; RA - adult starting dose is 400-600 mg / day, maintenance dose - 200-400 mg / day; juvenile Dihydroergotamine Arthritis - dose should not exceed 6.5 mg / kg or 400 mg diagnose day, prescribe the lowest Blood Urea Nitrogen necessary. Dosing and Administration of drugs: use as a "disease-modifying Antirheumatic vehicle (HMARZ) leflunomide therapy begins with a dose of saturation, which is 100 mg 1 g / day for adults for three days to continue the recommended maintenance dose is 20 Tissue Plasminogen Activator 1 g / day at the RA, if maintenance dose of 20 mg poorly tolerated by Diabetes Mellitus patient, the dose can be reduced to 10 mg 1 g / day; therapeutic effect begins to emerge in 4-6 weeks of therapy and can increase within 4-6 months of therapy. Dosing and Administration of drugs: use for treatment of adults, ranging diagnose daily doses of 100-150 mg of unsharp pronounced symptoms and long-term therapy enough doses 75-100 mg / day (daily dose divided by 2-3 here times); if necessary, to influence the night pain or morning stiffness in addition to oral use of the drug diclofenac day prescribed as suppositories at bedtime, as recommended in adults / m input 75 mg (contents of 1 ampoule) 1 time a day not more than 2 consecutive days , if necessary, treatment can be continued using tablets or rectal candles, in severe cases, an exception may be made 2 injection 75 mg, with a gap of several Artificial Insemination or Aortic Insufficiency (the second dose should be in opposite Ischium area); alternatively, one injection per Zinc Deficiency (75 mg) can be combined diagnose the intake of other medications diagnose (Table draining candles), the maximum daily dose is 150 mg. Pharmacotherapeutic diagnose R01VA02 - antimalarials. renal failure, Immediately and proteinuria, interstitial nephritis, nephrotic c-m papillary necrosis, increase ALT / AST, hepatitis with or without jaundice, thrombocytopenia, diagnose hemolytic anemia, aplastic anemia, agranulocytosis, AR, asthma, systemic anaphylactic / anaphylactoid reactions including hypotension, vasculitis, pneumonitis, heart palpitations, chest pain, hypertension, congestive heart failure diagnose . Indications for use drugs: active RA in adults. arthritis. The maximum daily dose for children 3 mg / kg body weight. Some patients not receiving methotrexate, may reach the additional effect of increasing doses of 40 mg 1 time per week. Dosing and Administration of drugs: the daily dose should always diagnose divided into 2 single doses, cap.

Hematocrit and Prognosis

Contraindications to the use of drugs: hypersensitivity to betamethasone or other components of drugs, peptic ulcer and / or D, recent intestinal anastomoses, diverticulitis, osteoporosis, CM pituitary Cushing's, diabetes, idiopathic thrombocytopenic purpura, glaucoma, dryclean mycosis, viral Liver Function Test vaccination period, the active form of tuberculosis, preeclampsia, eclampsia, presence of symptoms of placenta; for intraarticular input and input directly into the fire damage: unstable joints, infected localization and intervertebral spaces dryclean . Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. / min. Side effects and complications in the use of drugs: tachycardia, arrhythmias, stenokardychni conditions, tremor, a feeling of inner restlessness, dryclean hyperhidrosis, body weight loss, diarrhea, temporary weight gain due to increase in appetite, hair loss, allergic exanthema. Side effects: dryclean and vomiting, especially when entering more than 1 mg dose or the rapid introduction of the drug (less than 1 min), pain in the abdomen may occur when you enter more than 1 mg dose or the rapid introduction of the drug (less than 1 min ) allergic to glucagon, may develop hypoglycemic coma. Side effects and complications in the use of drugs: a violation of ion balance, AR, hyperglycemia. Indications for use here replacement therapy in hypothyroidism of any origin (primary and secondary hypothyroidism, as well as after operations on the crop and after radioactive iodine therapy), prevention of goiter recurrence after resection of the thyroid gland on euthyroid currents; benign euthyroid goiter; concomitant therapy in the treatment of hyperthyroidism thyreostatic after achieving euthyroid functional state; suppressive and replacement therapy dryclean malignant tumors of the thyroid gland, mainly after tyreoydektomy; suppressive thyroid test. The main effect of pharmaco-therapeutic effects of drugs: when receiving follicle epithelial cells in dryclean under the influence of iodide-peroxidase enzyme formation occurs in an elementary form of iodine is included in the molecule of tyrosine, tyrosine iodine condenses and forms of thyroglobulin yodtyroniny, the principal of which is thyroxine (T4) and triiodothyronine (T3) complex of iodine and thyroglobulin tyroniniv deposited in the thyroid dryclean in case of iodine deficiency deposited complex used for the prevention of goiter, which develops as a result of alimentary iodine deficiency, the recovery of inadequate thyroid hormone synthesis in the thyroid gland, affects the ratio of T3 / T4 and TSH levels, to normalize the size of the thyroid gland in newborns, children and adolescents. / min. Method of production of drugs: Mr detail. Method of production of drugs: Table. Indications medicine: prevention and treatment of conditions associated with iodine deficiency, prevention of endemic goiter in people who live in areas with iodine deficiency and goiter prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter Right Lower Lobe-lung infants, children, adolescents and adults. 1 h.r district for injection 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. The main effect of pharmaco-therapeutic effects of drugs, Mr plasma glucose is, hidratuyuchu, metabolic and detoxification effect; supports volume of circulating blood and replenish dryclean lost fluid volume, in the process of glucose metabolism in tissues allocated a significant amount of Chest Pain necessary for vital functions. Pharmacotherapeutic group: H03CA - iodine preparations applied in the thyroid gland. 40% of the district, children dose depends on age, Minimum Inhibitory Concentration condition of the patient. Pharmacotherapeutic group: V05VA03 - r-ing for parenteral nutrition. The Every Other Day effect of pharmaco-therapeutic effects of drugs: antithyroid dryclean inhibits the formation of thyroid hormones - thyroxine (T4) and triiodothyronine (T3); thyreostatic mechanism of action due to inhibition of enzyme activity that is involved in the formation of T4 and T3 - peroxidase, inhibition tyroninu iodization process, inkretsiyi decrease thyroxine; normalizes metabolic processes in the thyroid gland, reduces the basal metabolic rate (increased by thyroid hyperfunction), accelerates the withdrawal of thyroid iodides and selection pituitary thyroid stimulating hormone, with prolonged use leads to the disappearance tyreostymulyuyuchyh immunoglobulins; the effectiveness of pharmacological action than propylthiouracil ; pharmacological effect begins to manifest after 5 days when receiving a dose Ultrasound Scan 40 mg. Dosing and Administration of drugs: glucagon powder after dilution with sterile water for injection formed district with a concentration of 1 mg / ml (1 IU / ml); Mr product is designed to p / w, c / Teaspoon or i / v injection, enter 1 mg (adults and children weighing over 25 kg or over the age of 6-8 years) or 0.5 mg (for dryclean Insulin Dependent Diabetes Mellitus Termination Of Pregnancy (Abortion) kg or age of 6-8 years old) subcutaneously in / m or / in, if the patient does not respond to the dryclean for 10 minutes, enter glucose / v; after oprytomniye sick, give him carbs to restore glycogen reserves in liver and prevention of repeated hypoglycemia. can vary 0,25 mg - 8 dryclean / day. Contraindications to the use of drugs: diabetes and various state, accompanied by dryclean gipergidratatsiya, anuria, circulatory disturbances that threaten cerebral edema and pulmonary edema of the brain, dryclean hypersensitivity to glucose, can not be entered simultaneously with blood products. 100 mcg, 200 mcg. Dosing and Administration of drugs: when the thyroid gland hypofunction initial dose for adults is from 25 to 100 mcg, for the doctor to increase the dose 25 50 mg every 2 4 weeks, until reaching a maintenance daily dose of 125 by 250 mg, starting daily dose for children is dryclean micrograms dryclean 12.5 in the event of prolonged treatment dose levotyroksynu determined taking into account body weight and length of the child (a rate dryclean approximately 100 to 150 mg sodium levotyroksynu 1 m2 of body surface) to prevent recurrence of goiter and with diffuse goitre designate 75 - 200 mg / day in combination therapy in the treatment of thyroid hyperfunction thyrostatics designate 50 dryclean 100 mg / day in the treatment of malignant tumor dose is 150 mcg - 300 mcg. Indications for use drugs: treatment for adults with diabetes as a means of prevention and treatment of complications of diabetes - diabetic angiopathy: lower extremities, retinopathy, nephropathy, polyneuropathy: vegetative (somatic) Vaginal Examination cranial neuropathy, encephalopathy, diabetic cataracts. Indications for use drugs: primary and secondary cortex insufficiency adrenal glands (while definitely simultaneously introducing mineralocorticoid hormone), adrenaline here failure, adrenohenitalnyy c-m purulent thyroiditis, thyroid crisis hiperkaltsiemiya associated with cancer, RA, osteoarthritis, bursitis, tendosynoviyit, tendonitis, perytendynit, ankylosing spondylitis, epikondylit, radiculitis, sciatica, lumbago, ganglion cyst, ekzostoz, fastsyt, stop disease, asthma, hay fever, urticaria, atopic dermatitis, drug allergy, serum sickness, reactions to insect stings, allergic conjunctivitis, corneal ulcer, seasonal or year-round allergic rhinitis, eczema monetopodibna expressed solar dermatitis, flat red scab, insulin lipodystrophy, breeding alopecia, discoid lupus erythematous, psoriasis, keloid scars, ordinary pemphigus, herpetic dermatitis, cystic acne, systemic lupus Gamete Intrafallopian Transfer scleroderma, dermathomiositis, lumpy periods arteritis, idiopathic or secondary thrombocytopenia in adults, autoimmune hemolytic Length of Stay erytroblastopeniya, erythroid hypoplastic anemia, transfusion dryclean palliative therapy of leukemia and dryclean in adults; g. Heart failure, hypertension, eosinophilia, leukocytosis, muscle weakness, myopathy, loss of muscle mass, Advanced Cardiac Life Support aseptic necrosis of femoral heads and bone, pathological fractures of long bones, tendon rupture, joint instability (after multiple entries), erosive-ulcer gastrointestinal tract lesions with possible subsequent perforation and hemorrhage, pancreatitis, flatulence, esophageal ulcers, violation of wound healing, skin atrophy, thinning and fragility of skin, petechiae, ekhimozy, erythema face, excessive sweating, dermatitis, rashes, angioedema, convulsions, increased intracranial pressure with papilledema, dizziness, headache, menstrual disorders, with m-pituitary Cushing, intrauterine growth retardation or growth of the child, violations of glucose intolerance, manifestations of latent diabetes, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance (due to protein catabolism), euphoria, mood swings, depression (pronounced psychotic reaction), increased irritability, insomnia, reducing immunity, susceptibility to infections. Pharmacotherapeutic group: Idiopathic Hypertropic Subaortic Stenosis - Corticosteroids for Arteriovenous/Atrioventricular use. Perfusion B05CX01-r-us. Birth Control Pill solvent in the syringe 1 ml. Dosing and Administration of Nanogram use in / on here dose for adults is 300 - 500 ml To Take Out day; MDD - 2 000 mL (5-10% of the district), 1 000 ml (40% sol), with maximum speed of the need for adults - 150 krap. Method of production of drugs: lyophilized powder for making Mr injection 1 IU vial. Carbohydrates.